ROTHBLATT MARTINE A sold UTHR

December 17, 2025 · Form 4 insider transaction

ROTHBLATT MARTINE A sold 1,500 shares of United Therapeutics Corporation at $500.52 per share, a transaction worth $750.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
1,500
Price
$500.52
Total value
$750.8K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after2,630
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. The transactions reported on this Form 4 are the final trades under this plan.; This transaction was executed in multiple trades at prices ranging from $500.12 to $500.725. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
ROTHBLATT MARTINE A sold UTHR: December 17, 2025 | Insider Trading Screener